Physician profile
John N Khalifa
NPI 1134190341
$3,603.68
in general payments reported to CMS, 2019-2025
14 companies · $64.51 in 2025
The $64.51 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.80 · 2020: $86.18 · 2021: $3,081 · 2022: $186 · 2023: $58.20 · 2024: $62.15 · 2025: $64.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,007.87 | 2021-2023 | |
| Allergan, INC. | $211.68 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.08 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $63.54 | 2019-2024 | Breztri |
| Pfizer INC. | $35.62 | 2022-2024 | |
| Novo Nordisk INC | $29.86 | 2020 | |
| Upsher-Smith Laboratories LLC | $24.15 | 2021 | |
| Abbott Laboratories | $21.51 | 2025 | Eterna |
| Supernus Pharmaceuticals, INC. | $18.62 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.34 | 2019 | |
| Merck Sharp & Dohme LLC | $16.83 | 2019 | |
| Lilly USA, LLC | $16.32 | 2020 | |
| Exact Sciences Corporation | $15.93 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $14.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Khalifa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.